- Annual blood-based multicancer early detection screening significantly reduces late-stage cancer diagnoses and mortality.
- Annual screening provides more benefit compared to biennial screening.
- Biennial screening demonstrates higher positive predictive value and greater efficiency.
- Real-world benefits of screening could be less than estimated.
- The study aims to determine optimal screening intervals for multicancer early detection tests.
Source: BMJ Open
